Literature DB >> 16723606

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world.

Matthew E Falagas, Sofia K Kasiakou.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16723606      PMCID： PMC1479143          DOI： 10.1128/AAC.00101-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  1 in total

1.  Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors:  Sofia K Kasiakou; Argyris Michalopoulos; Elpidoforos S Soteriades; George Samonis; George J Sermaides; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191
  1 in total
  10 in total

1.  Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization.

Authors:  Jian Li; Roger L Nation; John D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2006-12       Impact factor: 5.191

2.  Inappropriate dose of enteral antimicrobials promotes resistance.

Authors:  L Silvestri; C Negri; N Taylor; D F Zandstra; H K F van Saene
Journal:  J Clin Microbiol       Date:  2013-05       Impact factor: 5.948

3.  Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

Authors:  M E Falagas; S K Kasiakou; D P Kofteridis; G Roditakis; G Samonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

Review 4.  The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.

Authors:  James A Driscoll; Steven L Brody; Marin H Kollef
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 6.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  Colistin in the 21st century.

Authors:  Roger L Nation; Jian Li
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

Review 8.  Current treatment of pseudomonal infections in the elderly.

Authors:  Georgios Pappas; Kaiti Saplaoura; Matthew E Falagas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Renal glycosuria as a novel early sign of colistin-induced kidney damage in mice.

Authors:  Sophia L Samodelov; Michele Visentin; Zhibo Gai; Stephanie Häusler; Gerd A Kullak-Ublick
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

10.  Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Acinetobacter baumannii Infection: A Case Report and Review of the Literature.

Authors:  Ziyu Li; Yuling An; Lijuan Li; Huimin Yi
Journal:  Infect Drug Resist       Date:  2022-03-31       Impact factor: 4.003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.